The ratio of intratumoral CD15+ neutrophils to CD8+ lymphocytes predicts recurrence in patients with gastric cancer after curative resection

IF 1.5 Q4 ONCOLOGY
Cancer reports Pub Date : 2024-06-04 DOI:10.1002/cnr2.2099
Junichiro Watanabe, Takashi Kimura, Zenichiro Saze, Naoya Sato, Yasuhide Kofunato, Teruhide Ishigame, Ryo Okada, Akira Kenjo, Koji Kono, Shigeru Marubashi
{"title":"The ratio of intratumoral CD15+ neutrophils to CD8+ lymphocytes predicts recurrence in patients with gastric cancer after curative resection","authors":"Junichiro Watanabe,&nbsp;Takashi Kimura,&nbsp;Zenichiro Saze,&nbsp;Naoya Sato,&nbsp;Yasuhide Kofunato,&nbsp;Teruhide Ishigame,&nbsp;Ryo Okada,&nbsp;Akira Kenjo,&nbsp;Koji Kono,&nbsp;Shigeru Marubashi","doi":"10.1002/cnr2.2099","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>An elevated neutrophil-to-lymphocyte ratio (NLR) in peripheral blood is an independent prognostic indicator of various cancers.</p>\n </section>\n \n <section>\n \n <h3> Aims</h3>\n \n <p>In this study, we aimed to investigate the prognostic relevance of the intratumoral immune cell balance in gastric cancer.</p>\n </section>\n \n <section>\n \n <h3> Methods and Results</h3>\n \n <p>The study included 82 patients who underwent curative resection for gastric cancer. The intratumoral cluster of differentiation (CD) 15- and CD8-positive cells were evaluated using immunohistochemical staining. Additionally, clinicopathological factors and prognoses were analyzed. Patients with high intratumoral CD15/CD8 ratios had significantly lower overall survival (OS) and relapse-free survival (RFS) compared to those with low CD15/CD8 ratios (<i>p</i> = .0026 and <i>p</i> &lt; .0001, respectively). Additionally, a high CD15/CD8 ratio was associated with lymph node metastasis (<i>p</i> = .019). Patients with high NLR had a significantly lower RFS than those with low NLR (<i>p</i> = .0050). Multivariate analysis revealed that the intratumoral CD15/CD8 ratio, NLR, and venous invasion were independent prognostic indicators of RFS (CD15/CD8 ratio: <i>p</i> &lt; .001, hazard ratio (HR) = 14.7, 95% confidence interval (CI) = 3.8–56.8; NLR: <i>p</i> = .010, HR = 5.4, 95% CI = 1.5–19.6; venous invasion: <i>p</i> = .005, HR = 7.4, 95% CI = 1.8–29.7).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>In summary, we found that the intratumoral CD15/CD8 ratio is an independent prognostic factor following gastric cancer resection and its increase is associated with lymph node metastasis and microscopic lymph vessel invasion. Immunological evaluation with additional aspects of innate immunity may be useful in predicting cancer prognosis.</p>\n </section>\n </div>","PeriodicalId":9440,"journal":{"name":"Cancer reports","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cnr2.2099","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.2099","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

An elevated neutrophil-to-lymphocyte ratio (NLR) in peripheral blood is an independent prognostic indicator of various cancers.

Aims

In this study, we aimed to investigate the prognostic relevance of the intratumoral immune cell balance in gastric cancer.

Methods and Results

The study included 82 patients who underwent curative resection for gastric cancer. The intratumoral cluster of differentiation (CD) 15- and CD8-positive cells were evaluated using immunohistochemical staining. Additionally, clinicopathological factors and prognoses were analyzed. Patients with high intratumoral CD15/CD8 ratios had significantly lower overall survival (OS) and relapse-free survival (RFS) compared to those with low CD15/CD8 ratios (p = .0026 and p < .0001, respectively). Additionally, a high CD15/CD8 ratio was associated with lymph node metastasis (p = .019). Patients with high NLR had a significantly lower RFS than those with low NLR (p = .0050). Multivariate analysis revealed that the intratumoral CD15/CD8 ratio, NLR, and venous invasion were independent prognostic indicators of RFS (CD15/CD8 ratio: p < .001, hazard ratio (HR) = 14.7, 95% confidence interval (CI) = 3.8–56.8; NLR: p = .010, HR = 5.4, 95% CI = 1.5–19.6; venous invasion: p = .005, HR = 7.4, 95% CI = 1.8–29.7).

Conclusion

In summary, we found that the intratumoral CD15/CD8 ratio is an independent prognostic factor following gastric cancer resection and its increase is associated with lymph node metastasis and microscopic lymph vessel invasion. Immunological evaluation with additional aspects of innate immunity may be useful in predicting cancer prognosis.

Abstract Image

瘤内 CD15+ 中性粒细胞与 CD8+ 淋巴细胞之比可预测胃癌患者根治性切除术后的复发情况
背景 外周血中中性粒细胞与淋巴细胞比值(NLR)升高是各种癌症的独立预后指标。 目的 本研究旨在探讨胃癌瘤内免疫细胞平衡与预后的相关性。 方法和结果 研究纳入了 82 例接受胃癌根治性切除术的患者。采用免疫组化染色法评估了瘤内分化簇(CD)15-和 CD8 阳性细胞。此外,还对临床病理因素和预后进行了分析。与 CD15/CD8 比率低的患者相比,瘤内 CD15/CD8 比率高的患者总生存期(OS)和无复发生存期(RFS)明显较低(分别为 p = .0026 和 p <.0001)。此外,高 CD15/CD8 比值与淋巴结转移有关(p = .019)。高NLR患者的RFS明显低于低NLR患者(p = .0050)。多变量分析显示,瘤内 CD15/CD8 比值、NLR 和静脉侵犯是 RFS 的独立预后指标(CD15/CD8 比值:p < .001,危险比 (HR) = 14.7,95% 置信区间 (CI) = 3.8-56.8;NLR:p = .010,HR = 5.4,95% CI = 1.5-19.6;静脉侵犯:p = .005,HR = 7.4,95% CI = 1.8-29.7)。 结论 综上所述,我们发现瘤内 CD15/CD8 比值是胃癌切除术后的一个独立预后因素,其升高与淋巴结转移和微小淋巴管侵犯有关。对先天性免疫的其他方面进行免疫学评估可能有助于预测癌症预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer reports
Cancer reports Medicine-Oncology
CiteScore
2.70
自引率
5.90%
发文量
160
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信